Recommendations for the use of albumin and immunoglobulins.
作者信息
Liumbruno Giancarlo Maria, Bennardello Francesco, Lattanzio Angela, Piccoli Pierluigi, Rossettias Gina
机构信息
UU.OO.CC. di Immunoematologia e Medicina Trasfusionale e Patologia Clinica, Ospedale San Giovanni Calibita Fatebenefratelli, Roma, Italy.
出版信息
Blood Transfus. 2009 Jul;7(3):216-34. doi: 10.2450/2009.0094-09.
Abstract
摘要
相似文献
1
Recommendations for the use of albumin and immunoglobulins.
Blood Transfus. 2009 Jul;7(3):216-34. doi: 10.2450/2009.0094-09.
2
Are intravenous immunoglobulins really inappropriate in acquired von Willebrand syndrome?
Blood Transfus. 2012 Jul;10(3):402-3; author reply 404-5. doi: 10.2450/2011.0091-11. Epub 2012 Dec 22.
3
Potential Creutzfeldt-Jakob disease (CJD) exposure: to notify or not to notify.
Transfus Sci. 1997 Sep;18(3):491-2. doi: 10.1016/s0955-3886(97)00047-7.
4
[The transfusion of blood and its derivatives in the neonate].
Bol Med Hosp Infant Mex. 1991 Nov;48(11):836-40.
5
Safety and tolerability of intravenous immunoglobulins.
Electroencephalogr Clin Neurophysiol Suppl. 1999;50:514-20.
6
Intravenous immunoglobulins.
BMJ. 1991 Aug 17;303(6799):375-6. doi: 10.1136/bmj.303.6799.375.
7
[Aseptic meningitis during treatment with very low doses of intravenous immunoglobulins].
Rev Med Interne. 1998 Feb;19(2):140-1. doi: 10.1016/s0248-8663(97)83428-5.
8
Different batches of human albumin solutions from one manufacturer may induce heterogenous cardiovascular effects.
Intensive Care Med. 2000 Jul;26(7):1011-2. doi: 10.1007/s001340051300.
9
Anaphylactoid reaction to human albumin microspheres.
J Nucl Med. 1975 Mar;16(3):236-7.
10
Rapid infusion of intravenous immunoglobulin in patients with neuromuscular diseases.
Neurology. 2002 May 14;58(9):1444. doi: 10.1212/wnl.58.9.1444.
引用本文的文献
1
Evaluation of the Efficacy of a Nomogram to Predict Multidrug-Resistant Pulmonary Infections Based on Data from Neurosurgery Ward Patients.
Infect Drug Resist. 2025 Jul 26;18:3723-3734. doi: 10.2147/IDR.S527114. eCollection 2025.
2
Effect of human serum albumin on clinical outcomes in pediatric patients undergoing gastrointestinal surgery.
Front Pediatr. 2025 Jul 16;13:1590586. doi: 10.3389/fped.2025.1590586. eCollection 2025.
3
Prognostic value of postoperative decrease of albumin (ΔAlb) in combination with GLIM-defined malnutrition for the prediction of postoperative outcomes in rectal cancer patients with normal preoperative albumin levels.
Front Nutr. 2025 May 13;12:1542581. doi: 10.3389/fnut.2025.1542581. eCollection 2025.
4
Hyperoncotic human albumin solutions for intravenous fluid therapy: Effectiveness of pathogen safety and purification methods, and clinical safety.
Biosaf Health. 2022 Dec 17;5(1):21-29. doi: 10.1016/j.bsheal.2022.12.004. eCollection 2023 Feb.
5
Effect of hypoalbuminemia on drug pharmacokinetics.
Front Pharmacol. 2025 Feb 20;16:1546465. doi: 10.3389/fphar.2025.1546465. eCollection 2025.
6
Rational use of human albumin: plan-do-check-act cycle in clinical practice.
BMJ Support Palliat Care. 2025 Aug 26;15(5):648-654. doi: 10.1136/spcare-2024-005268.
7
Is human albumin injection the best choice to treat hypoalbuminemia?
PLoS One. 2024 Oct 21;19(10):e0311949. doi: 10.1371/journal.pone.0311949. eCollection 2024.
8
Assessment of Albumin Usage Patterns and Appropriateness in a Comprehensive Cancer Centre: A retrospective study in Jordan.
Sultan Qaboos Univ Med J. 2024 Aug;24(3):354-359. doi: 10.18295/squmj.6.2024.029. Epub 2024 Aug 29.
9
Preoperative Hypoalbuminemia Predicts 30-day Complications in Head and Neck Microvascular Surgery.
Laryngoscope. 2025 Feb;135(2):648-656. doi: 10.1002/lary.31716. Epub 2024 Aug 21.
10
Influence of postoperative hypoalbuminemia and human serum albumin supplementation on incision healing following total knee arthroplasty for knee osteoarthritis: a retrospective study.
Sci Rep. 2024 Jul 29;14(1):17354. doi: 10.1038/s41598-024-68482-9.
本文引用的文献
1
Colloids versus crystalloids for fluid resuscitation in critically ill patients.
Cochrane Database Syst Rev. 2007 Oct 17(4):CD000567. doi: 10.1002/14651858.CD000567.pub3.
2
Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
Ann Pharmacother. 2007 May;41(5):812-23. doi: 10.1345/aph.1K037. Epub 2007 Apr 17.
3
Guidelines on the use of intravenous immune globulin for hematologic conditions.
Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S9-56. doi: 10.1016/j.tmrv.2007.01.001.
4
Guidelines on the use of intravenous immune globulin for neurologic conditions.
Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S57-107. doi: 10.1016/j.tmrv.2007.01.002.
5
Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions.
Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S3-8. doi: 10.1016/j.tmrv.2007.01.004.
6
Guidelines for the use of intravenous immune globulin for hematologic and neurologic conditions.
Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S1-2. doi: 10.1016/j.tmrv.2007.01.003.
7
Modern plasma fractionation.
Transfus Med Rev. 2007 Apr;21(2):101-17. doi: 10.1016/j.tmrv.2006.11.001.
8
Immunotherapy for Guillain-Barré syndrome: a systematic review.
Brain. 2007 Sep;130(Pt 9):2245-57. doi: 10.1093/brain/awm004. Epub 2007 Mar 2.
9
Safety of intravenous immunoglobulin (IVIG) therapy.
Autoimmun Rev. 2007 Mar;6(4):257-9. doi: 10.1016/j.autrev.2006.08.011. Epub 2006 Aug 28.
10
Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders.
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD004761. doi: 10.1002/14651858.CD004761.pub2.
Zotero 插件